☰

Ramzey J. Abujarour, Ph.D. - Publications

Affiliations: 
2005 University of Texas at Dallas, Richardson, TX, United States 
Area:
Cell Biology, Microbiology Biology
Tree Info Similar researchers PubMed Report error

37 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Abujarour R, Dinella J, Pribadi M, Fong LK, Denholtz M, Gutierrez A, Haynes M, Mahmood E, Lee TT, Ding S, Valamehr B. A chemical approach facilitates CRISPRa-only human iPSC generation and minimizes the number of targeted loci required. Future Science Oa. 10: FSO964. PMID 38817352 DOI: 10.2144/fsoa-2023-0257  0.653
2024 van der Stegen SJC, Lindenbergh PL, Petrovic RM, Xie H, Diop MP, Alexeeva V, Shi Y, Mansilla-Soto J, Hamieh M, Eyquem J, Cabriolu A, Wang X, Abujarour R, Lee T, Clarke R, et al. Author Correction: Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells. Nature Biomedical Engineering. PMID 38347164 DOI: 10.1038/s41551-024-01181-y  0.343
2023 Hammer Q, Perica K, van Ooijen H, Mbofung R, Momayyezi P, Varady E, Martin KE, Pan Y, Jelcic M, Groff B, Abujarour R, Krokeide S, Lee T, Williams A, Goodridge JP, et al. Genetic ablation of adhesion ligands averts rejection of allogeneic immune cells. Biorxiv : the Preprint Server For Biology. PMID 37873468 DOI: 10.1101/2023.10.09.557143  0.318
2022 Cichocki F, Bjordahl R, Goodridge JP, Mahmood S, Gaidarova S, Abujarour R, Davis ZB, Merino A, Tuininga K, Wang H, Kumar A, Groff B, Witty A, Bonello G, Huffman J, et al. Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma. Nature Communications. 13: 7341. PMID 36446823 DOI: 10.1038/s41467-022-35127-2  0.332
2022 van der Stegen SJC, Lindenbergh PL, Petrovic RM, Xie H, Diop MP, Alexeeva V, Shi Y, Mansilla-Soto J, Hamieh M, Eyquem J, Cabriolu A, Wang X, Abujarour R, Lee T, Clarke R, et al. Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells. Nature Biomedical Engineering. PMID 35941192 DOI: 10.1038/s41551-022-00915-0  0.335
2021 Woan KV, Kim H, Bjordahl R, Davis ZB, Gaidarova S, Goulding J, Hancock B, Mahmood S, Abujarour R, Wang H, Tuininga K, Zhang B, Wu CY, Kodal B, Khaw M, et al. Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy. Cell Stem Cell. PMID 34525347 DOI: 10.1016/j.stem.2021.08.013  0.367
2020 Mandal M, Clarke R, Stegen Svd, Chang C, Lai Y, Witty A, Husain M, Wu C, Yang B, Dufaud C, Hsia G, Shaked H, Stokely L, Chu H, Pribadi M, ... ... Abujarour R, et al. Abstract 3245: FT819 path to IND: First-of-kind off-the-shelf CAR19 T-cell for B cell malignancies Immunology. DOI: 10.1158/1538-7445.Am2020-3245  0.357
2019 Zhu H, Blum R, Bjordahl R, Gaidarova S, Rogers P, Lee TT, Abujarour R, Bonello GB, Wu J, Tsai PF, Miller JS, Walcheck B, Valamehr B, Kaufman DS. Pluripotent stem cell-derived NK cells with high-affinity non-cleavable CD16a mediate improved anti-tumor activity. Blood. PMID 31856277 DOI: 10.1182/Blood.2019000621  0.507
2019 Bjordahl R, Gaidarova S, Goodridge JP, Mahmood S, Bonello G, Robinson M, Ruller C, Pribadi M, Lee T, Abujarour R, Dinella J, Huffman J, Chu H, Hopken U, Rehm A, et al. FT576: A Novel Multiplexed Engineered Off-the-Shelf Natural Killer Cell Immunotherapy for the Dual-Targeting of CD38 and Bcma for the Treatment of Multiple Myeloma Blood. 134: 3214-3214. DOI: 10.1182/Blood-2019-131373  0.309
2019 Chang C, Van Der Stegen S, Mili M, Clarke R, Lai Y, Witty A, Lindenbergh P, Yang B, Husain M, Shaked H, Groff B, Stokely L, Abujarour R, Lee T, Chu H, et al. FT819: Translation of Off-the-Shelf TCR-Less Trac-1XX CAR-T Cells in Support of First-of-Kind Phase I Clinical Trial Blood. 134: 4434-4434. DOI: 10.1182/Blood-2019-130584  0.434
2019 Abujarour R, Lai Y, Pribadi M, Lee T, Robinson M, Ruller C, Stegen SVd, Wang X, Stefanski J, Zhen J, Dinella J, Bonello G, Huffman J, Chu H, Clarke R, et al. Abstract LB-073: Generation of novel single cell-derived engineered master pluripotent cell line as a renewable source for off-the-shelf TCR-less CAR T cells in support of first-of-kind clinical trial Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-073  0.478
2019 Bjordahl R, Zhu H, Rogers P, Gaidarova S, Ge MQ, Blum R, Cichocki F, Goodridge J, Chu H, Bonello G, Lee T, Groff B, Abujarour R, Walcheck B, Miller J, et al. Abstract 3191: FT516, an off-the-shelf engineered NK cell therapeutic product for universal anti-tumor targeting strategy in combination with monoclonal antibodies Cancer Research. 79: 3191-3191. DOI: 10.1158/1538-7445.Am2019-3191  0.425
2018 Clarke R, Van Der Stegen S, Chang C, Husain M, Lai Y, Peralta E, Stokely L, Abujarour R, Dinella J, Lee T, Pribadi M, Chu H, Truong C, Sabouri-Ghomi M, Meza M, et al. Pluripotent Cell-Derived Off-the-Shelf TCR-Less CAR-Targeted Cytotoxic T Cell Therapeutic for the Allogeneic Treatment of B Cell Malignancies Blood. 132: 4546-4546. DOI: 10.1182/Blood-2018-99-116843  0.414
2018 Bjordahl R, Mahmood S, Gaidarova S, Abujarour R, Clarke R, Stokely L, Rogers P, Ge M, Robinson M, Rezner B, Lee TT, Valamehr B. Abstract 3576: FT500, an off-the-shelf NK cell cancer immunotherapy derived from a master pluripotent cell line, enhances T-cell activation and recruitment to overcome checkpoint blockade resistance Cancer Research. 78: 3576-3576. DOI: 10.1158/1538-7445.Am2018-3576  0.381
2017 Cichocki F, Bjordahl R, Gaidarova S, Rogers P, Clarke R, Groff B, Moreno S, Abujarour R, Robinson M, Bonello G, Lee T, Lan W, Rezner B, Abbot S, Sumstad D, et al. Clinical Translation of Pluripotent Cell-Derived Off-the-Shelf Natural Killer Cell Cancer Immunotherapy Blood. 130: 656-656. DOI: 10.1182/Blood.V130.Suppl_1.656.656  0.508
2017 Bjordahl R, Clarke R, Gaidarova S, Bauer M, Sasaki J, Groff B, Lee T, Lan W, Abujarour R, Bonello G, Robinson M, Hardy I, Shoemaker D, Valamehr B. Multi-Functional Genetic Engineering of Pluripotent Cell Lines for Universal Off-the-Shelf Natural Killer Cell Cancer Immunotherapy Blood. 130: 3187-3187. DOI: 10.1182/Blood.V130.Suppl_1.3187.3187  0.504
2017 Bjordahl R, Cichocki F, Clarke R, Gaidarova S, Groff B, Rogers P, Moreno S, Abujarour R, Bonello G, Lee T, Lan W, Bauer M, Robbins D, Rezner B, Cooley S, et al. Abstract 3755: Renewable and genetically engineered natural killer cells for off-the-shelf adoptive cellular immunotherapy Cancer Research. 77: 3755-3755. DOI: 10.1158/1538-7445.Am2017-3755  0.428
2016 Abujarour R, Lan W, Lee TT, Bonello G, Meza M, Robinson M, Clarke R, Truong C, Lynn C, Robbins D, Rezner B, Abbot SE, Shoemaker D, Valamehr B. Efficient Site-Specific Multi-Gene Engineering of Renewable Pluripotent Cells for Generation of Off-the-Shelf Hematopoietic Immunotherapeutics Blood. 128: 5887-5887. DOI: 10.1182/Blood.V128.22.5887.5887  0.513
2016 Bjordahl R, Clarke R, Gaidarova S, Groff B, Rogers P, Moreno S, Abujarour R, Bonello G, Lee TT, Lan W, Burrascano M, Bauer M, Robinson M, Sasaki J, Kim W, et al. Off-the-Shelf Natural Killer Cell Immunotherapy for Enhanced Antibody Directed Cellular Cytotoxicity Blood. 128: 3363-3363. DOI: 10.1182/Blood.V128.22.3363.3363  0.476
2016 Bauer M, Clarke R, Sasaki J, Groff B, Lee TT, Lan W, Abujarour R, Bonello G, Burrascano M, Robinson M, Bjordahl R, Gaidarova S, Abbot SE, Wolchko S, Shoemaker D, et al. Genetic Engineering of Pluripotent Cells for the Continuous Derivation of Off-the-Shelf Effector Lymphocytes with Enhanced Therapeutic Persistence By Overcoming the Host Histocompatibility Barrier Blood. 128: 2165-2165. DOI: 10.1182/Blood.V128.22.2165.2165  0.522
2016 Clarke R, Groff B, Sasaki J, Bauer M, Lee TT, Lan W, Burrascano M, Abujarour R, Bonello G, Robinson M, Foster H, Robbins D, Wolchko S, Shoemaker D, Abbot SE, et al. Genetically Enhanced Pluripotent Stem Cell-Derived T Lymphocytes for Off-the-Shelf Cellular Immunotherapy Blood. 128: 2164-2164. DOI: 10.1182/Blood.V128.22.2164.2164  0.525
2015 Abujarour R, Valamehr B. Generation of skeletal muscle cells from pluripotent stem cells: advances and challenges Frontiers in Cell and Developmental Biology. 3: 29-29. PMID 26029693 DOI: 10.3389/Fcell.2015.00029  0.574
2015 Huang X, Lan W, Parone P, Clarke R, Abujarour R, Robinson M, Meza M, Raynel S, Rezner B, Robbins D, Lee TT, Shoemaker D, Valamehr B. Human Induced Pluripotent Stem Cells Incorporating Safe Harbor Loci Integrated Inducible Suicide Systems for Use in the Application of Cellular Therapeutics Blood. 126: 3237-3237. DOI: 10.1182/Blood.V126.23.3237.3237  0.505
2015 Clarke R, Kim W, Groff B, Abujarour R, Robinson M, Huang X, Sahaf N, Raynel S, Rezner B, Robbins D, Guerrettaz L, Shoemaker D, Valamehr B. A Platform for the Scalable Derivation of Genetically-Enhanced T and NK Lymphocytes from Naive Human Induced Pluripotent Stem Cells for Cancer Immunotherapy Blood. 126: 2364-2364. DOI: 10.1182/Blood.V126.23.2364.2364  0.585
2014 Galasso M, Dama P, Previati M, Sandhu S, Palatini J, Coppola V, Warner S, Sana ME, Zanella R, Abujarour R, Desponts C, Teitell MA, Garzon R, Calin G, Croce CM, et al. A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma. Genome Medicine. 6: 76. PMID 25352916 DOI: 10.1186/S13073-014-0076-4  0.732
2014 Volinia S, Nuovo G, Drusco A, Costinean S, Abujarour R, Desponts C, Garofalo M, Baffa R, Aeqilan R, Maharry K, Sana ME, Garzon ME, Di Leva G, Gasparini P, Dama P, et al. Pluripotent stem cell miRNAs and metastasis in invasive breast cancer. Journal of the National Cancer Institute. 106. PMID 25306216 DOI: 10.1093/Jnci/Dju324  0.721
2014 Valamehr B, Robinson M, Abujarour R, Rezner B, Vranceanu F, Le T, Medcalf A, Lee TT, Fitch M, Robbins D, Flynn P. Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells. Stem Cell Reports. 2: 366-81. PMID 24672758 DOI: 10.1016/J.Stemcr.2014.01.014  0.529
2014 Abujarour R, Bennett M, Valamehr B, Lee TT, Robinson M, Robbins D, Le T, Lai K, Flynn P. Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery. Stem Cells Translational Medicine. 3: 149-60. PMID 24396035 DOI: 10.5966/Sctm.2013-0095  0.547
2013 Abujarour R, Valamehr B, Robinson M, Rezner B, Vranceanu F, Flynn P. Optimized surface markers for the prospective isolation of high-quality hiPSCs using flow cytometry selection. Scientific Reports. 3: 1179. PMID 23378912 DOI: 10.1038/Srep01179  0.437
2012 Valamehr B, Abujarour R, Robinson M, Le T, Robbins D, Shoemaker D, Flynn P. A novel platform to enable the high-throughput derivation and characterization of feeder-free human iPSCs. Scientific Reports. 2: 213. PMID 22355727 DOI: 10.1038/Srep00213  0.566
2010 Abujarour R, Efe J, Ding S. Genome-wide gain-of-function screen identifies novel regulators of pluripotency. Stem Cells (Dayton, Ohio). 28: 1487-97. PMID 20629179 DOI: 10.1002/Stem.472  0.768
2010 Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J, Chinnaiyan A, Israel MA, Goldstein LS, Abujarour R, Ding S, Guan KL. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes & Development. 24: 1106-18. PMID 20516196 DOI: 10.1101/Gad.1903310  0.684
2009 Li W, Zhou H, Abujarour R, Zhu S, Young Joo J, Lin T, Hao E, Schöler HR, Hayek A, Ding S. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells (Dayton, Ohio). 27: 2992-3000. PMID 19839055 DOI: 10.1002/Stem.240  0.748
2009 Lin T, Ambasudhan R, Yuan X, Li W, Hilcove S, Abujarour R, Lin X, Hahm HS, Hao E, Hayek A, Ding S. A chemical platform for improved induction of human iPSCs. Nature Methods. 6: 805-8. PMID 19838168 DOI: 10.1038/Nmeth.1393  0.601
2009 Abujarour R, Ding S. Induced pluripotent stem cells free of exogenous reprogramming factors. Genome Biology. 10: 220. PMID 19439061 DOI: 10.1186/Gb-2009-10-5-220  0.726
2005 Abujarour RJ, Dalal S, Hanson PI, Draper RK. p97 Is in a complex with cholera toxin and influences the transport of cholera toxin and related toxins to the cytoplasm. The Journal of Biological Chemistry. 280: 15865-71. PMID 15691847 DOI: 10.1074/Jbc.M406316200  0.586
2003 Chen A, AbuJarour RJ, Draper RK. Evidence that the transport of ricin to the cytoplasm is independent of both Rab6A and COPI. Journal of Cell Science. 116: 3503-10. PMID 12865434 DOI: 10.1242/Jcs.00641  0.655
Show low-probability matches.